RetinalGenix Technologies Inc.
RTGN
$3.20
-$0.35-9.86%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -22.93% | 1.30% | 9.35% | -72.20% | 56.49% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -28.17% | -11.74% | -2.17% | -72.66% | 60.18% |
| Operating Income | 28.17% | 11.74% | 2.17% | 72.66% | -60.18% |
| Income Before Tax | 28.13% | 11.72% | 2.14% | 72.63% | -60.08% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 28.13% | 11.72% | 2.14% | 72.63% | -60.08% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 28.13% | 11.72% | 2.14% | 72.63% | -60.08% |
| EBIT | 28.17% | 11.74% | 2.17% | 72.66% | -60.18% |
| EBITDA | 28.16% | 11.74% | 2.16% | 72.67% | -60.16% |
| EPS Basic | 30.13% | 14.76% | 4.84% | 73.89% | -55.19% |
| Normalized Basic EPS | 30.10% | 14.73% | 4.74% | 73.91% | -55.73% |
| EPS Diluted | 30.13% | 14.76% | 4.84% | 73.89% | -55.19% |
| Normalized Diluted EPS | 30.10% | 14.73% | 4.74% | 73.91% | -55.73% |
| Average Basic Shares Outstanding | 2.72% | 3.39% | 2.59% | 4.81% | 3.18% |
| Average Diluted Shares Outstanding | 2.72% | 3.39% | 2.59% | 4.81% | 3.18% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |